You are viewing the site in preview mode

Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a “real world” STEMI population: results from the Italian “CARDIO-STEMI SANREMO” registry

Fig. 2

Kaplan–Meier analysis of 4-year survival in the non-PG-l patients (blue line) and the PG-l patients, stratified by the cumulative number of risk factors present. The table shows the number of patients in each risk group. Abbreviation: PG-l = PEGASUS-TIMI 54-like patients

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us